Retrophin Inc

FDA Filings

This page includes the latest FDA filings for Retrophin Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USANASDAQRTRXDUNS 965454502
FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Travere Therapeutics
Prescription Medication2023-07-08
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2023-04-04
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2022-11-18
Travere Therapeutics
Prescription Medication2021-12-02
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2021-11-30
Travere Therapeutics
Prescription Medication2021-08-11
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2020-12-15
Travere Therapeutics
Prescription Medication2020-12-11
Travere Therapeutics
Prescription Medication2020-06-13
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2020-06-12
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S
Prescription Medication2019-07-13
Travere Therapeutics
Prescription Medication2019-07-13
Retrophin, Inc.
Chenodal2015-12-28
Retrophin, Inc
Cholbam2015-03-31
Retrophin, Inc
Cholbam2015-03-31

Similar & Related FDA Registered Companies

Related Finance Registrations
NCAGE Code77HN5RETROPHIN, INC.
CAGE Code77HN5RETROPHIN, INC.
S.A.M. Registration77HN5 [965454502]RETROPHIN, INC.
SEC0001438533Retrophin, Inc. of DELAWARE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.